Antivirals Drug - Worldwide Market Analysis, Trends and Forecasts (2019-2025): Nucleotide Polymerase Inhibitors Displays the Potential to Grow at Over 3.5% During the Forecast Period - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 27, 2019--
The “Antivirals Drug - Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering.
The Antivirals Drug market worldwide is projected to grow by US$13.7 Billion, driven by a compounded growth of 3.9%.
Nucleotide Polymerase Inhibitors, one of the segments analyzed and sized in this study, displays the potential to grow at over 3.5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$14.7 Billion by the year 2025, Nucleotide Polymerase Inhibitors will bring in healthy gains adding significant momentum to global growth.
Representing the developed world, the United States will maintain a 3.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$499.6 Million to the region’s size and clout in the next 5 to 6 years. Over US$407.6 Million worth of projected demand in the region will come from the rest of the European markets.
In Japan, Nucleotide Polymerase Inhibitors will reach a market size of US$705.1 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6% over the next couple of years and add approximately US$3.8 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.
Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East.
All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include:
- AbbVie, Inc.
- Aurobindo Pharma Ltd.
- Bristol-Myers Squibb Company
- Cipla Ltd.
- Dr. Reddy’s Laboratories Ltd.
- F. Hoffmann-La Roche AG
- Gilead Sciences, Inc.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Merck & Co. Inc.
- Mylan N.V.
For more information about this report visit https://www.researchandmarkets.com/r/p14t3j
View source version on businesswire.com:https://www.businesswire.com/news/home/20191127005585/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 11/27/2019 12:50 PM/DISC: 11/27/2019 12:50 PM